Krishna Ella emphasizes AI's transformative potential in biology, predicting unprecedented advancements and commercial shifts ...

Bharat Biotech is considering a $500 million IPO, aiming to expand its vaccine portfolio. Learn about its global impact and ...

Promoted by Dr Krishna Ella, the vaccine manufacturer serves both domestic and export markets and remains entirely ...

Vaccine developer Bharat Biotech International Ltd is mulling over a public listing that is expected to raise over $500 ...

Indian vaccine developer Bharat Biotech International Ltd is considering an initial public offering that may raise more than ...

Bharat Biotech is seeking to raise over $500 million through an IPO. Discussions are ongoing, and details may change. Established in 1996, the company has distributed over 9 billion vaccines worldwide ...

The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over ...

GSK plc (NYSE:GSK) is one of the 12 best healthcare stocks to buy now. On June 12, the company announced licensing its Shigella vaccine candidate to Bharat Biotech. The licensing is part of the ...

NEW DELHI, March 1 (Reuters) - A Chinese state-backed hacking group has in recent weeks targeted the IT systems of two Indian vaccine makers whose coronavirus shots are being used in the country's ...

Indian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than ...

Indian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than ...

Indian vaccine developer Bharat Biotech International Ltd. is considering an initial public offering that may raise more than ...